At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02652 CF PHARMTECH
Market Closed 10-16 16:08:16
5.980
+0.070
+1.18%
High6.150Low5.770Vol1.96M
Open6.150D1 Closing5.910Amplitude6.43%
Mkt Cap2.58BTradable Cap1.93BTotal Shares432.00M
T/O11.60MT/O Rate0.61%Tradable Shares323.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Chairman and CEO Liang Wenqing Increases Stake in CF PharmTech (02652) by 19,300 Shares at Approximately HK$6.92 Per Share
Stock News  ·  10-09
Chairman and CEO Liang Wenqing Increases Stake in CF PharmTech (02652) by 19,300 Shares at Approximately HK$6.92 Per Share
CF PHARMTECH Repurchases 89,300 Shares for HK$499,600 on October 8
Stock News  ·  10-08
CF PHARMTECH Repurchases 89,300 Shares for HK$499,600 on October 8
CF PharmTech Repurchases 89,300 H-Shares for HKD 0.50 Million, Lifts Treasury Stock to 2.11 Million Shares
Bulletin Express  ·  10-08
CF PharmTech Repurchases 89,300 H-Shares for HKD 0.50 Million, Lifts Treasury Stock to 2.11 Million Shares
CF PharmTech Spends HKD 499,600 to Buy Back 74,800 Shares on October 7
Stock News  ·  10-07
CF PharmTech Spends HKD 499,600 to Buy Back 74,800 Shares on October 7
CF PharmTech repurchases 74,800 H-shares, boosting treasury stock to 2.02 million units
Bulletin Express  ·  10-07
CF PharmTech repurchases 74,800 H-shares, boosting treasury stock to 2.02 million units
CF PharmTech Reduces Outstanding H-Shares by 0.02% via HK$0.50 Million Buyback
Bulletin Express  ·  10-06
CF PharmTech Reduces Outstanding H-Shares by 0.02% via HK$0.50 Million Buyback
CF PharmTech Monthly Update: Share Capital Steady at RMB 433.73 Million; 337.80 Thousand H-Shares Moved to Treasury in September 2026
Bulletin Express  ·  10-06
CF PharmTech Monthly Update: Share Capital Steady at RMB 433.73 Million; 337.80 Thousand H-Shares Moved to Treasury in September 2026
Operating Cash Flow Turns Positive Sharply and Operating Efficiency Jumps Significantly: CF PharmTech (02652) Interim Report Releases Key Signals
Stock News  ·  10-06
Operating Cash Flow Turns Positive Sharply and Operating Efficiency Jumps Significantly: CF PharmTech (02652) Interim Report Releases Key Signals
CF PharmTech Core Management Voluntarily Extends Share Lock-Up by Six Months
Bulletin Express  ·  10-05
CF PharmTech Core Management Voluntarily Extends Share Lock-Up by Six Months
CF PharmTech Core Management Voluntarily Extends Share Lock-Up Period by Six Months
Stock News  ·  10-05
CF PharmTech Core Management Voluntarily Extends Share Lock-Up Period by Six Months
CF PharmTech Repurchases 71,800 Shares for HK$499,700 on October 2
Stock News  ·  10-02
CF PharmTech Repurchases 71,800 Shares for HK$499,700 on October 2
CF PharmTech Buys Back 71,800 H Shares, Treasury Stock Climbs to 1.81 Million
Bulletin Express  ·  10-02
CF PharmTech Buys Back 71,800 H Shares, Treasury Stock Climbs to 1.81 Million
CF PHARMTECH: Bill Wenqing Liang Acquires Shares, Long Position Rises to 18.74%
HK Disclosure  ·  10-02
CF PHARMTECH: Bill Wenqing Liang Acquires Shares, Long Position Rises to 18.74%
CF PHARMTECH: Pyramid Investment Limited Acquires Shares, Long Position Rises to 14.3%
HK Disclosure  ·  10-02
CF PHARMTECH: Pyramid Investment Limited Acquires Shares, Long Position Rises to 14.3%
CF PHARMTECH: Li Li Bovet Acquires Shares, Long Position Rises to 18.74%
HK Disclosure  ·  10-02
CF PHARMTECH: Li Li Bovet Acquires Shares, Long Position Rises to 18.74%
CF PharmTech Buys Back 144,600 H Shares, Treasury Stock Rises to 1.73 Million
Bulletin Express  ·  09-30
CF PharmTech Buys Back 144,600 H Shares, Treasury Stock Rises to 1.73 Million
CF PharmTech Adds 67,900 H Shares to Treasury via HK$0.49 Million Buyback
Bulletin Express  ·  09-29
CF PharmTech Adds 67,900 H Shares to Treasury via HK$0.49 Million Buyback
CF PharmTech Spends HK$489,100 to Buy Back 67,900 Shares on September 29
Stock News  ·  09-29
CF PharmTech Spends HK$489,100 to Buy Back 67,900 Shares on September 29
CF PharmTech Repurchases 125,300 Shares for HK$948,800 on September 28
Stock News  ·  09-28
CF PharmTech Repurchases 125,300 Shares for HK$948,800 on September 28
AI-Driven Innovation at the Source: Targeting a Globally Scarce Inhaled Anti-Inflammatory Pipeline, CF Pharmtech Doubles Down on Novel Mechanisms for Pulmonary Delivery
Stock News  ·  09-23
AI-Driven Innovation at the Source: Targeting a Globally Scarce Inhaled Anti-Inflammatory Pipeline, CF Pharmtech Doubles Down on Novel Mechanisms for Pulmonary Delivery

Introduction

Company Name.
CF PHARMTECH
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
CF PharmTech, Inc. is a China-based company primarily the research and development, production and sale of respiratory drugs and other related medical products. The Company’s product portfolio primarily focused on respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. The Company's primary products include CF017, a budesonide suspension for inhalation targeting bronchial asthma, and CF018, an azelastine hydrochloride and fluticasone propionate nasal spray approved for allergic rhinitis. The Company mainly conducts its business in the domestic market.
Issue price:
--